Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. [electronic resource]
Producer: 20100408Description: 49-54 p. digitalISSN:- 1468-3288
- Acute Disease
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- blood
- Antibody Formation
- Cohort Studies
- Colectomy
- Colitis, Ulcerative -- blood
- Colonoscopy
- Drug Administration Schedule
- Drug Monitoring -- methods
- Female
- Gastrointestinal Agents -- blood
- Humans
- Infliximab
- Male
- Middle Aged
- Prognosis
- Remission Induction
- Risk Assessment -- methods
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.